{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:22:52Z","timestamp":1773062572905,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10815-015-0602-3","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T09:31:35Z","timestamp":1446715895000},"page":"1749-1756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"32","author":[{"given":"Laura","family":"Detti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather E.","family":"Jeffries-Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Uhlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"602_CR1","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"602_CR2","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR3","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ecl.2013.10.003","volume":"43","author":"A Nandi","year":"2014","unstructured":"Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2014;43:123\u201347.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"602_CR5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165\u201374.","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"602_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13697130903003842","volume":"12","author":"E Carmina","year":"2009","unstructured":"Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric. 2009;12 Suppl 1:22\u20135.","journal-title":"Climacteric"},{"key":"602_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28\u201338.e25.","journal-title":"Fertil Steril"},{"key":"602_CR8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","volume":"114","author":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins\u2014Gynecology","year":"2009","unstructured":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins\u2014Gynecology. ACOG practice bulletin no. 108: polycystic ovary syndrome. Obstet Gynecol. 2009;114:936\u201349.","journal-title":"Obstet Gynecol"},{"key":"602_CR9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038\u201349.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR10","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/jc.2013-2040","volume":"98","author":"A Dunaif","year":"2013","unstructured":"Dunaif A, Fauser BC. Renaming PCOS\u2014a two-state solution. J Clin Endocrinol Metab. 2013;98:4325\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","volume":"7","author":"N Gleicher","year":"2007","unstructured":"Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev. 2007;7:42\u20135.","journal-title":"Autoimmun Rev"},{"key":"602_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1500363","volume":"150","author":"OE Janssen","year":"2004","unstructured":"Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gartner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363\u20139.","journal-title":"Eur J Endocrinol"},{"key":"602_CR13","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.fertnstert.2010.05.063","volume":"94","author":"J Ott","year":"2010","unstructured":"Ott J, Aust S, Kurz C, Nouri K, Wirth S, Huber JC, et al. Elevated antithyroid peroxidase antibodies indicating Hashimoto\u2019s thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil Steril. 2010;94:2895\u20137.","journal-title":"Fertil Steril"},{"key":"602_CR14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/jc.2007-0141","volume":"92","author":"M Abalovich","year":"2007","unstructured":"Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007;92:S1\u201347.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR15","first-page":"202","volume":"45","author":"S Hahan","year":"2007","unstructured":"Hahan S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med. 2007;45:202\u20137.","journal-title":"Clin Chem Lab Med"},{"key":"602_CR16","first-page":"1355","volume":"58","author":"J Mayfield","year":"1998","unstructured":"Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Phis Ass. 1998;58:1355\u201362. 1369\u201370.","journal-title":"Am Phis Ass"},{"key":"602_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-7-26","volume":"7","author":"A Esteghamati","year":"2010","unstructured":"Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab. 2010;7:7\u201326.","journal-title":"Nutr Metab"},{"key":"602_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57\u201363.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"602_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","volume":"18","author":"PS Jellinger","year":"2012","unstructured":"Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American association of clinical endocrinologists\u2019 guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2012;18 Suppl 1:1\u201378.","journal-title":"Endocr Pract"},{"key":"602_CR20","unstructured":"ADA practice Guidelines: http:\/\/mcintranet.musc.edu\/agingq3\/calculationswesbite\/ADA%20Guidelines\/ADA%20Binder.pdf ; accessed on January 31, 2015."},{"key":"602_CR21","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocrin Rev. 1997;18:774\u2013800.","journal-title":"Endocrin Rev"},{"key":"602_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","volume":"16","author":"DA Ehrmann","year":"1995","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen production. Endocr Rev. 1995;16:322\u201353.","journal-title":"Endocr Rev"},{"key":"602_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Ritmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95:1073\u20139.e1-11.","journal-title":"Fertil Steril"},{"key":"602_CR25","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","volume":"88","author":"RC Christian","year":"2003","unstructured":"Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy 2nd PF, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2562\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"602_CR26","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.fertnstert.2010.06.041","volume":"94","author":"A Reh","year":"2010","unstructured":"Reh A, Grifo J, Danoff A. What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization. Fertil Steril. 2010;94:2920\u20132.","journal-title":"Fertil Steril"},{"key":"602_CR27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.fertnstert.2013.05.027","volume":"100","author":"L Detti","year":"2013","unstructured":"Detti L, Uhlmann RA, Fletcher NM, Diamond MP, Saed GM. Endometrial signaling pathways during ovarian stimulation for assisted reproductive technology. Fertil Steril. 2013;100:889\u201394.","journal-title":"Fertil Steril"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-015-0602-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-015-0602-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-015-0602-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:21:28Z","timestamp":1559265688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-015-0602-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s10815-015-0602-3","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}